DYNAMICALLY TUNABLE PHOTONIC BANDGAP MICROCAVITY WAVEGUIDES VIA MECHANICAL LATTICE CONTROL

Details for Australian Patent Application No. 2003256546 (hide)

Owner MASSACHUSETTS INSTITUTE OF TECHNOLOGY

Inventors WONG, Chee, Wei; BARBASTATHIS, George; KIM, Sang-Gook; JOHNSON, Steven, G.

Pub. Number AU-A-2003256546

PCT Number PCT/US03/22083

PCT Pub. Number WO2004/008231

Priority 60/395,926 15.07.02 US; 60/467,854 05.05.03 US; 10/619,203 14.07.03 US

Filing date 15 July 2003

Wipo publication date 2 February 2004

International Classifications

G02F 001/01 Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating - for the control of the intensity, phase, polarisation or colour

G02B 006/12 Light guides - of the integrated circuit kind

Event Publications

6 November 2003 Complete Application Filed

  Priority application(s): 60/395,926 15.07.02 US; 60/467,854 05.05.03 US; 10/619,203 14.07.03 US

18 March 2004 Application Open to Public Inspection

  Published as AU-A-2003256546

12 May 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003256547-Safety shield for medical needles

2003256545-METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IgE SYNTHESIS UTILIZING A THIOREDOXIN-LIKE 32 kDA PROTEIN